Genomics

Dataset Information

0

IL-2/CD25: A Long-Acting Fusion Protein That Promotes Immune Tolerance by Selectively Targeting the IL-2 Receptor on Regulatory T Cells


ABSTRACT: Low-dose IL-2 represents an immunotherapy to selectively expand regulatory T cells (Tregs) to promote tolerance in patients with autoimmunity. In this article, we show that a fusion protein (FP) of mouse IL-2 and mouse IL-2Rα (CD25), joined by a noncleavable linker, has greater in vivo efficacy than rIL-2 at Treg expansion and control of autoimmunity. Biochemical and functional studies support a model in which IL-2 interacts with CD25 in the context of this FP in trans to form inactive head-to-tail dimers that slowly dissociate into an active monomer. In vitro, IL-2/CD25 has low sp. act. However, in vivo IL-2/CD25 is long lived to persistently and selectively stimulate Tregs. In female NOD mice, IL-2/CD25 administration increased Tregs within the pancreas and reduced the instance of spontaneous diabetes. Thus, IL-2/CD25 represents a distinct class of IL-2 FPs with the potential for clinical development for use in autoimmunity or other disorders of an overactive immune response.

ORGANISM(S): Mus musculus

PROVIDER: GSE113951 | GEO | 2018/08/27

REPOSITORIES: GEO

Similar Datasets

2024-01-16 | GSE219259 | GEO
2021-05-11 | GSE164937 | GEO
2022-04-07 | GSE200142 | GEO
2017-05-24 | GSE80814 | GEO
2014-01-22 | E-GEOD-50646 | biostudies-arrayexpress
2019-02-01 | GSE121883 | GEO
2011-03-21 | E-MEXP-2689 | biostudies-arrayexpress
2011-01-06 | E-MEXP-2530 | biostudies-arrayexpress
2022-02-16 | GSE162030 | GEO
2022-02-16 | GSE163946 | GEO